Uh-oh! This study is no longer available.
Blood Sample – Diagnosed With or At Risk for Hepatocellular Carcinoma
Hepatocellular Carcinoma (Liver Disease)
PMG Research of Winston Salem
A research study is collecting blood samples to better understand biomarkers in adults recently diagnosed with or at risk for developing Hepatocellular Carcinoma (HCC). Those with hepatitis B or C, nonalcoholic steatohepatitis (NASH), cirrhosis or other forms of liver disease may be at risk.
This research study may be an option if you:
• Have been clinically diagnosed with HCC within the last 6 months or do not have a diagnosis and are undergoing routine imaging surveillance for HCC
• Do not have a history of current or prior treatment for HCC
• Have not been treated with chemotherapy and/or radiation in the past 5 years
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Patient Commitment Duration
Approximately 2 hours
Financial compensation will be provided for time and travel expenses.
Number of visits in study
Approximately 1-2 clinic visits